Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland - Wikidata - wikimedia - TriplyDB

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

http://www.wikidata.org/entity/Q33896893

about

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas Progress in molecular-based management of differentiated thyroid cancer Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature Pax-8-PPAR-γ fusion protein in thyroid carcinoma Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Thyroid cancer: current molecular perspectives.Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.Oncogenes and thyroid cancer.The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers Molecular approaches to thyroid cancer diagnosis.Molecular pathogenesis and mechanisms of thyroid cancer p53: the barrier to cancer stem cell formation.Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours.Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas.Recent advances in molecular diagnosis of thyroid cancer.Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.Genome-wide appraisal of thyroid cancer progression.Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays Gene therapy for thyroid cancer.Poorly differentiated thyroid carcinoma: an incubating entity.Analysis of adenomatous polyposis coli gene in thyroid tumours Zn(II)-curc targets p53 in thyroid cancer cells Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma Pathogenetic mechanisms in thyroid follicular-cell neoplasia.Genetic considerations in thyroid cancer.Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation Recent progress of genome study for anaplastic thyroid cancer.Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.

P2860

Q24646800-B0C2A8C3-AFBB-4F35-98F8-3821F7BBE2B9 Q24651210-A949CB4C-3009-472E-91B9-8BFE3960D921 Q26999887-48D26020-0E57-4808-B45A-8A704CC90BE0 Q27025120-E60789B4-149A-411D-B449-8C263BE556DF Q28244806-A2FFF186-A232-431D-90BD-76AB715FE314 Q33182004-F59D2F58-7D4F-49CD-A53B-97E8FC7D41C9 Q33691759-0C1D1357-EB13-43E8-8B6A-175849447667 Q33760910-CD11B485-0A0D-4266-8D66-22113E754FFF Q33861404-19B8D864-5DC9-4855-BAEF-424F5D51F8BF Q33914771-0F065170-955F-4CC0-A495-38BCADDDECD0 Q33931296-691DBA5C-A2B6-4CAF-B32A-F90B8AC6B460 Q33940788-5E9D3354-C0DE-4C32-AD0C-461E674C30F6 Q34119098-500851C1-E959-48E8-9255-9DEF6C599CF9 Q34123724-549CA8C9-CE34-4F77-B80F-8A31E26B4B18 Q34160828-CCDE1BDF-2771-41AD-818F-A8C58BADE32F Q34329018-D3116E22-64C5-4656-9827-CF6ABC71579C Q34406072-191941FE-7DF4-48B1-A01B-FCA9880A85E0 Q34592276-A897585B-647D-4D8F-85E2-7E0E07D1582A Q34945075-C9FAF86F-A67F-44C3-ADB3-D37D2429125F Q34985320-4540E1C1-6F0B-4972-B634-82B964D27DD3 Q35051065-A4830B3A-B485-4A6A-AF90-A5337B26D3C1 Q35622067-B84AD666-A0F5-4256-8109-4BF088E9A896 Q35698913-057BFE52-1CE1-42A7-A38E-3CA47C5DDFE8 Q35731037-8321A996-F07F-4384-8653-0FF4896E9A98 Q35745674-D9C59C5A-9051-40D8-9C4F-EB0A337753F3 Q35747698-33F783D4-660F-4304-B0E3-9AA77D495DF2 Q35787996-B3162B7F-7DC9-48FF-9A8C-CD6EAA5E7D37 Q35788634-772C690D-B6E1-49EC-9136-19923E955ED9 Q35842601-BB77F670-3B1F-4763-B76A-BD06625B8668 Q36050222-8811209C-C864-4D88-9E0B-5E20BCCEAC0E Q36080630-DFB6DE85-B576-454F-800E-3A010E0E0E0B Q36094135-1CD997B5-CE50-4885-8E8E-B4F40869BB28 Q36138917-C4D6A29F-CC29-4548-966C-4DE38D00424A Q36294984-0C8BA782-9F61-4064-9C44-8B8555EFCB32 Q36430189-0B516730-3E5C-4533-9450-77395F6C29A5 Q36493223-3ED00570-DBFD-40C1-BF15-A99F4D534EEA Q36618604-D96E6ADA-DE5E-4655-9019-B62904A907A3 Q36643400-08FC8732-D779-49FE-9859-8A49CCE05228 Q36992782-E5290411-85A9-4050-8D8F-48B755C9231D Q37035285-EE2CCD65-6C3C-4DF7-8160-99E0BEB37606

P2860

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

http://www.wikidata.org/entity/Q33896893

description

1993 nî lūn-bûn

@nan

1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@ast

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@en

type

label

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@ast

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@en

prefLabel

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@ast

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@en

P1433

Q33896893-E8C24D20-D699-473A-8E32-477FF5271F4E

P1476

Q33896893-2A049FEC-D65C-44D5-B5D7-1947ADC57014

P2093

Q33896893-261656F7-D35F-41CF-A4FE-27E3E3B2FB47

Q33896893-2A15F9F3-3243-40F8-A7C7-35ACDAAA17A3

Q33896893-46359900-B8E7-4748-AD82-7612AA0FCE83

Q33896893-86F5F464-5951-4014-BCB5-83BE78C08199

Q33896893-F31C947F-6523-44DF-AF17-9630308790DD

P2860

Q33896893-024592FD-0B49-48F0-9836-02CDC10150FF

Q33896893-12D6FCEB-A8D6-42E1-849E-C097BF62A506

Q33896893-1477E824-B7C8-4674-9905-858F56C12A88

Q33896893-2F8B23B7-5027-4902-AD0F-FD2908E00572

Q33896893-33AF3DA1-0233-4787-A9B7-4819599BA68B

Q33896893-46D7BF39-E105-423E-8064-2F76C6F55A11

Q33896893-52F754DA-678B-4875-8F50-CB0C0BD0C720

Q33896893-5F040406-34BE-41A8-91BC-B95BC0453FF7

Q33896893-667DF7CE-1019-4A36-8782-D2CE0052F37C

Q33896893-73569B7B-429F-4410-B7D8-DE5A63D2D936

P304

Q33896893-34FE7C05-F143-4990-9335-5F0185F9F642

P31

Q33896893-8B46CF97-A321-46B8-9FFA-EDD066A7328D

P356

Q33896893-44C87968-7C6B-407D-B8EA-0D38120FC618

P407

Q33896893-67E8E584-1F6A-487F-8290-2661B75F4078

P433

Q33896893-B7592E22-3EF2-4134-ADC6-C5B492B9B265

P478

Q33896893-47199ED6-8F48-48EC-938C-1352E70742B4

P50

Q33896893-C3B01961-DFED-4238-BF7A-C2C258789509

P577

Q33896893-276A661C-44BC-4FBD-9813-F0CB8E6D84A2

P5875

Q33896893-015B69B9-6AD9-4691-8013-8662D686F48E

P698

Q33896893-1F257F1A-AFCA-44DE-BFDF-94E00BE26A61

P932

Q33896893-6B76F9D9-3604-4915-A691-4C4513E9B80E

P356

P1433

Journal of Clinical Investigation

P1476

Gene p53 mutations are restric ...... arcinomas of the thyroid gland

@en

P2093

Della Porta G

http://www.w3.org/2001/XMLSchema#string

Donghi R

http://www.w3.org/2001/XMLSchema#string

Longoni A

http://www.w3.org/2001/XMLSchema#string

Michieli P

http://www.w3.org/2001/XMLSchema#string

Pilotti S

http://www.w3.org/2001/XMLSchema#string

P2860

p53 mutations in human cancers

The trk proto-oncogene encodes a receptor for nerve growth factor

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

Clonal expansion of p53 mutant cells is associated with brain tumour progression.

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Improved double-stranded DNA sequencing using the linear polymerase chain reaction.

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

The p53 tumour suppressor gene.

Structural aspects of the p53 protein in relation to gene evolution.

P304

1753-1760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116385

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Marco A. Pierotti

P577

1993-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14724828

http://www.w3.org/2001/XMLSchema#string

P698

8473515

http://www.w3.org/2001/XMLSchema#string

P932

288155

http://www.w3.org/2001/XMLSchema#string